Delivery Order SPE2DB22D6029-SPE2DB24FT9WJ
Award Date 2/2/24
Potential Completion Date 2/5/24
Potential Value $2.7K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 20,000 unit vials of the pharmaceutical product RECOTHROM. The $30,695.68 contract has a completion date of January 22, 2024. As a prime contractor, AmerisourceBergen Drug Corp has an extensive history of providing pharmaceuticals, medical supplies, and distribution services to support DLA's Troop Support Medical programs....
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $2,403.54 firm fixed-price contract is for the delivery of 20,000 unit vials of RECOTHROM, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen with DLA Troop Support Medical, which...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 20,000 unit vials of the pharmaceutical product RECOTHROM. The $17,797.92 delivery order is part of a larger indefinite delivery contract, with an unspecified potential value, between Amerisourcebergen Drug Corp and DLA Troop Support Medical to supply pharmaceuticals and medical supplies in support of military treatment programs...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $10,723.95 order is for the supply of 5,000 unit vials of the specialty medication RECOTHROM, with a period of performance through March 25, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA that serves as the primary vehicle for the company...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,513.82 fixed-price delivery order is for the supply of 20,000 unit vials of RECOTHROM, a specialty medication. The contract has a period of performance through December 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $8,154.79 firm fixed price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 20,000 unit vials of the pharmaceutical product RECOTHROM, with a completion date of September 4, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous Indefinite Delivery Contracts (IDCs) by DLA and other federal agencies, valued up to $999,999,999,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 20,000 unit vials of the pharmaceutical product RECOTHROM, with a ceiling value of $17,757.76 and a completion date of December 23, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a $1,335.30 firm-fixed-price delivery order to AmerisourceBergen Drug Corporation's Corporate Office Division for the supply of 20,000 units of the pharmaceutical product RECOTHROM. This delivery order falls under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical, which provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $13,497.83 firm fixed-price contract is for the delivery of 20,000 unit vials of the pharmaceutical product RECOTHROM. The contract has an ultimate completion date of August 28, 2024 and was awarded on August 27, 2024. This contract does not have a set-aside designation. As a major supplier of pharmaceutical products and medical supplies to the U.S....
- This federal contract award, with ID SPE2DB22D3501|SPE2DB25FTL61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,259.84 firm-fixed-price delivery order is for 20,000 unit vials of RECOTHROM, a medical product, with a completion date of November 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB24FT9WJDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 20,000 unit vials of RECOTHROM pharmaceutical product. The $2,670.60 order has a completion date of February 5, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to military treatment programs and facilities worldwide. No set-aside designation was used for this award.
Generated 5/3/24, 9:41 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 2/2/24 |